In leukemia, allogeneic HCT is beneficial following primary induction failure.

Published Date: 27 Dec 2023

A study published online suggests that immediate allogeneic hematopoietic stem cell transplantation (HCT) following primary induction failure (PIF) improves long-term survival for patients with acute myeloid leukemia (AML).

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In leukemia, allogeneic HCT is beneficial following primary induction failure.

2.

FDA Approves Sickle Cell Gene Therapy for Young Kids

3.

According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.

4.

Research exposes far-reaching toll of financial hardship on patients with cancer

5.

Combination Treatment May Improve Multiple Myeloma Outcomes


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot